Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   T-cell responses to KSHV infection: a systematic approach
  2. Roshan, Romin; Labo, Nazzarena; Trivett, Matthew; Miley, Wendell; Marshall, Vickie; Coren, Lori; Cornejo Castro, Elena; Perez, Hannah; Holdridge, Benjamin; Davis, Eliza; Matus Nicodemos, Rodrigo; Ayala, Victor I; Sowder, Raymond; Wyvill, Kathleen; Aleman, Karen; Fennessey, Christine; Lifson, Jeffrey; Polizzotto, Mark N; Douek, Daniel; Keele, Brandon; Uldrick, Thomas; Yarchoan, Robert; Ohlen, Claes; Ott, David; Whitby, Denise
  3. Oncotarget. 2017, Dec 12; 8(65): 109402-109416.
  1. 2.   Immunological monitoring of the tumor immunoenvironment for clinical trials
  2. Malyguine, A. M.; Strobl, S. L.; Shurin, M. R.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 239-247.
  1. 3.   Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
  2. Butterfield, L. H.; Palucka, A. K.; Britten, C. M.; Dhodapkar, M. V.; Hakansson, L.; Janetzki, S.; Kawakami, Y.; Kleen, T. O.; Lee, P. P.; Maccalli, C.; Maecker, H. T.; Maino, V. C.; Maio, M.; Malyguine, A.; Masucci, G.; Pawelec, G.; Potter, D. M.; Rivoltini, L.; Salazar, L. G.; Schendel, D. J.; Slingluff, C. L.; Song, W. R.; Stroncek, D. F.; Tahara, H.; Thurin, M.; Trinchieri, G.; van Der Burg, S. H.; Whiteside, T. L.; Wigginton, J. M.; Marincola, F.; Khleif, S.; Fox, B. A.; Disis, M. L.
  3. Clinical Cancer Research. 2011, May; 17(10): 3064-3076.
  1. 4.   New flow cytometric assays for monitoring cell-mediated cytotoxicity
  2. Zaritskaya, L.; Shurin, M. R.; Sayers, T. J.; Malyguine, A. M.
  3. Expert Review of Vaccines. 2010, Jun; 9(6): 601-616.
  1. 5.   A systematic approach to biomarker discovery, Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
  2. Butterfield, L. H.; Disis, M. L.; Fox, B. A.; Lee, P. P.; Khleif, S. N.; Thurin, M.; Trinchieri, G.; Wang, E.; Wigginton, J.; Chaussabel, D.; Coukos, G.; Dhodapkar, M.; Hakansson, L.; Janetzki, S.; Kleen, T. O.; Kirkwood, J. M.; Maccalli, C.
  3. Journal of Translational Medicine. 2008 6 AR 81
  1. 6.   ELIspot displays a better detection over ELISA of T helper (Th) 2-type cytokine-production by ex vivo-stimulated antigen-specific T cells from human peripheral blood
  2. Minang, J. T.; Arestrom, I.; Ahlborg, N.
  3. Immunological Investigations. 2008 37(4): 279-291.
  1. 7.   New approaches for monitoring CTL activity in clinical trials
  2. Malyguine, A.; Strobl, S.; Zaritskaya, L.; Baseler, M.; Shafer-Weaver, K.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 273-284.
  1. 8.   Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials
  2. Shaftr-Weaver, K.; Rosenberg, S.; Strobl, S.; Alvord, W. G.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2006, May-Jun; 29(3): 328-335.
  1. 9.   Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIV(mac)239
  2. Evans, D. T.; Bricker, J. E.; Sanford, H. B.; Lang, S.; Carville, A.; Richardson, B. A.; Piatak, M.; Lifson, J. D.; Mansfield, K. G.; Desrosiers, R. C.
  3. Journal of Virology. 2005, JUN; 79(12): 7707-7720.
  1. 10.   A novel flow cytometric assay for evaluating cell-mediated cytotoxicity
  2. Burkett, M. W.; Weaver, K. A. S.; Strobl, S.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2005, JUL-AUG; 28(4): 396-402.
  1. 11.   Dueling ELISPOTS: Use of the IFN-gamma, GrB, or dual color IFN-gamma/GrB ELISPOT assay for immunological monitoring
  2. Shafer-Weaver, K. A.; Zartiskaya, L.; Strobl, S.; Luck, T.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 634-634.
  1. 12.   Optimization of a dendritic cell based whole protein ELISPOT assay for immunological monitoring
  2. Strobl, S. L.; Zaritskaya, L.; Shafer-Weaver, K.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 634-635.
  1. 13.   Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection
  2. Gloster, S. E.; Newton, P.; Cornforth, D.; Lifson, J. D.; Williams, I.; Shaw, G. M.; Borrow, P.
  3. Aids. 2004 18(5): 749-755.
  1. 14.   The IFN-gamma and GrB elispot assays: Partners for monitoring clinical immune responses
  2. Shafer-Weaver, K.; Ulderich, T.; Strobl, S.; Baseler, M.; Malyguine, A.
  3. Journal of Immunotherapy. 2004, NOV-DEC; 27(6): S43-S43.
  1. 15.   Use of interleukin 15 to enhance interferon-gamma production by antigen-specific stimulated lymphocytes from rhesus macaques
  2. Calarota, S. A.; Otero, M.; Hermanstayne, K.; Lewis, M.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.; Boyer, J. D.; Weiner, D. B.
  3. Journal of Immunological Methods. 2003 279(1-2): 55-67.
  1. 16.   Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants
  2. Zhao, J.; Lou, Y. M.; Pinczewski, J.; Malkevitch, N.; Aldrich, K.; Kalyanaraman, V. S.; Venzon, D.; Peng, B.; Patterson, L. J.; Edghill-Smith, Y.; Woodward, R.; Pavlakis, G. N.; Robert-Guroff, M.
  3. Vaccine. 2003 21(25-26): 4022-4035.
  1. 17.   Correlation of human CD56(+) cell cytotoxicity and IFN-gamma production
  2. Derby, E. G.; Reddy, V.; Nelson, E. L.; Kopp, W. C.; Baseler, M. W.; Dawson, J. R.; Malyguine, A. M.
  3. Cytokine. 2001 13(2): 85-90.
  1. 18.   Assessing Antigen-Specific Cellular Immune Responses upon HIV /SIV Plasmid DNA Vaccination in the Nonhuman Primate Model
  2. Hu,Xintao; Felber,Barbara; Valentin,Antonio
  3. Methods in molecular biology (Clifton, N.J.). 2021 2197: 113-131.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel